A multi-centre, double-blind, randomized, controlled trial compaing different regimens of the antibiotics doxycycline and rifampin for treatment of Alzheimer's disease with an open-label extension - DARAD

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
David W
Principal Investigator Last Name
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
Funding Organization
Funding Organization Country